Connect with us

Hi, what are you looking for?

Investing

Completion of Divesture of Non-US Assets

Published

Hydration solutions company The Hydration Pharmaceuticals Company Limited (ASX: HPC) (“Hydralyte US” or “the Company”) refers to its announcement released pre-open on 2 October 2024 regarding entry into an Intellectual Property Sales Agreement (the ‘Agreement’) and related documents with Prestige Consumer Healthcare Inc. and associated subsidiaries.

Hydralyte US is pleased to announce that the Agreement has completed and the sale proceeds of approximately US$9.45m (A$13.7m) have been received.

Click here for the full ASX Release

This post appeared first on investingnews.com
In this article:
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Investing

Graphite Market Update: H1 2024 in Review

Battery metals like graphite are becoming increasingly important for their role in battery technologies. Both synthetic and natural graphite, in the form of spherical...

August 6, 2024

Investing

Zinc Price Update: H1 2024 in Review

2023 was volatile for zinc — as the bottom fell out of the market, it approached its lowest point since July 2020. As 2024...

August 9, 2024

Politics

Typhoon Yagi kills dozens in Vietnam, China, Philippines

Typhoon Yagi, Asia’s most powerful storm this year, was downgraded to a tropical depression on Sunday, after wreaking havoc in northern Vietnam, China’s Hainan...

September 8, 2024

Investing

Los Andes Copper Announces Positive PFS for Vizcachitas with a US$2.77 Billion Post-Tax NPV and 24% IRR

Los Andes Copper Ltd. (TSXV: LA) (OTCQX: LSANF) (‘Los Andes’ or the ‘Company’) is pleased to announce the results of a positive Pre-Feasibility Study...

August 7, 2024